VU 0365114

Discontinued Product

4404 has been discontinued.

View all M<sub>5</sub> Receptors products.
说明: Positive allosteric modulator of M5 receptors
化学名: 1-[(1,1'-Biphenyl)-4-ylmethyl]-5-(trifluoromethoxy)-1H-indole-2,3-dione
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for VU 0365114

VU 0365114 is a selective positive allosteric modulator of M5 (EC50 values are 2.7 μM for human M5, and >30 μM for M1, M2, M3 and M4 receptors).

技术数据 for VU 0365114

分子量 397.35
公式 C22H14F3NO3
储存 Store at RT
纯度 ≥98% (HPLC)
CAS Number 1208222-39-2
PubChem ID 45281794
InChI Key SPBGRXOPAXZSER-UHFFFAOYSA-N
Smiles O=C(C1=CC(OC(F)(F)F)=CC=C1N2CC3=CC=C(C4=CC=CC=C4)C=C3)C2=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

参考文献 for VU 0365114

参考文献是支持产品生物活性的出版物。

Bridges et al (2010) Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part I: development of the first highly selective M5 PAM. Bioorg.Med.Chem.Lett. 20 558 PMID: 20004578

Bridges et al (2010) Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators. Bioorg.Med.Chem.Lett. 20 5617 PMID: 20801651

按产品操作查看相关产品

查看全部 M5 Receptor Modulators

关键词: VU 0365114, VU 0365114 supplier, VU0365114, acetylcholine, muscarinics, machrs, receptors, positive, allosteric, modulators, pams, m5, M5, Receptors, 4404, Tocris Bioscience

篇 VU 0365114 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 VU 0365114 的引用文献。

VU 0365114 的评论

目前没有该产品的评论。 Be the first to review VU 0365114 and earn rewards!

Have you used VU 0365114?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.